title: Neuropeptide Y and lipid increase apolipoprotein AIV gene expression in rat hypothalamus.
abstract: Apolipoprotein AIV (apo AIV) is a circulating signal released from intestinal cells in response to lipid feeding and contributes to the anorectic effect of a lipid meal. We have demonstrated that apo AIV is also synthesized in the hypothalamus, and that hypothalamic apo AIV gene expression is regulated physiologically. Neuropeptide Y (NPY) is a hypothalamic neuropeptide with broad regulatory actions in the central nervous system. In the present studies, the effects of intracerebroventricular (i.v.t.) administration of NPY and of intraduodenal lipid infusion on hypothalamic apo AIV gene expression were determined using competitive RT-PCR in fasted rats. I.v.t. injection of NPY alone significantly increased apo AIV mRNA levels in the hypothalamus in a dose-dependent manner. Intraduodenal infusion of lipid also stimulated the gene expression of hypothalamic apo AIV, but no further significant increment occurred when i.v.t. injection of NPY was combined with lipid infusion. These results suggest that NPY and lipid may regulate apo AIV gene expression in the rat hypothalamus.
authors.affiliation: Cincinnati Obesity Research Center, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA. lium@email.uc.edu
authors.forename: Min
authors.initials: M
authors.lastname: Liu
authors.forename: Ling
authors.initials: L
authors.lastname: Shen
authors.forename: Takashi
authors.initials: T
authors.lastname: Doi
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Woods
authors.forename: Randy J
authors.initials: RJ
authors.lastname: Seeley
authors.forename: Patrick
authors.initials: P
authors.lastname: Tso
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001054:Apolipoproteins A / Q000235:genetics* / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D008055:Lipids / Q000494:pharmacology*; D008297:Male; D009478:Neuropeptide Y / Q000494:pharmacology*; D012313:RNA / Q000032:analysis; D012333:RNA, Messenger / Q000096:biosynthesis; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods
chemical_list: D001054:Apolipoproteins A; D008055:Lipids; D009478:Neuropeptide Y; D012333:RNA, Messenger; C022205:apolipoprotein A-IV; D012313:RNA; D005947:Glucose